The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 640.00
Bid: 640.00
Ask: 650.00
Change: 0.00 (0.00%)
Spread: 10.00 (1.563%)
Open: 640.00
High: 0.00
Low: 0.00
Prev. Close: 640.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Seal

9 Jul 2008 07:00

RNS Number : 6172Y
Porvair PLC
09 July 2008
 



For immediate release 9 July 2008

Porvair plc 

("Porvair" or the "Group")

Acquisition of Seal Analytical Ltd

Porvair plc today announces the acquisition of Seal Analytical Ltd ("Seal"), a leading manufacturer of water quality analysis equipment for environmental and industrial laboratories. The acquisition allows Porvair to build on its position in water quality markets and brings immediate opportunities for cost savings and revenue growth.

Seal is being acquired from its shareholders who include The South East Growth Fund and Tim Brittain, Seal's Managing Director.

The acquisition values Seal's ordinary and preference share capital at up to £3.8 million (net of option receipts), to be settled by up to £2.3 million of cash and up to £1.5 million of shares in Porvair (the "Consideration Shares"). Porvair will also assume £2.2 million of Seal's existing bank borrowings and £0.3 million of finance leases for a total consideration of a maximum of £6.3 million pending net asset adjustments of up to £0.5 million. Seal had gross assets of £3.9 million at 30 June 2007, including goodwill of £1.2 million.

For the financial year ended 30 June 2008, Seal is expected to report revenues of approximately £7.6 million (2007: £6.0 million) and PBT of approximately £0.5 million (2007: loss of £0.7 million).

Seal's main products, analysis instruments and related consumables are highly regarded. Its seawater testing systems are the industry standard and it has grown its US business to be the market leader in the past four years. Seal is based in the UK and has larger operations in the USA and Germany. Around 15% of sales revenues are to UK customers. Key management will remain with the business following the acquisition. 

The global water quality equipment market is growing stronglyWater testing is generally mandatory and must be done using approved methods to which Seal's products conform. Independent estimates predict market growth of 11% per annum in the period 2008 - 2011 as water quality standards tighten across the world and laboratories automate their processes to achieve more consistent results. Seal has a good position in the well defined 'wet chemistry' segment of the market, which is concerned with the detection of inorganic contaminants in water.

Porvair already supplies this market with laboratory consumables, porous plastics and water filters and these existing activities will benefit from the strength of Seal's customer relationships. The board has also identified cost and operational benefits in the transaction and plans to expand Seal's product offering and geographic reach by using the wider scope of the Group. 

The acquisition is expected to be earnings enhancing in the first full year of ownership

Application will be made to the UK Listing Authority and the London Stock Exchange for the Consideration Shares to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange.

Commenting on the transaction, Ben Stocks, Chief executive of Porvair said:

"For some time we have been looking at ways of expanding our presence in water quality, a field closely related to the filtration we already do. Water quality concerns are growing around the world, driven by population growth, water scarcity and pollutionIn response, governments are expanding water quality standards, mandating testing by approved methods. The combined Porvair and Seal businesses are ideally placed to serve this growing requirement for domestic and commercial clean water analysis. We are excited by the business opportunities that this acquisition presents and we are pleased to welcome Seal's management and staff to the Porvair group."

For further information please contact:

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Altium

Nick Tulloch

Paul Chamberlain

Buchanan Communications

020 7484 4040

020 7466 5000

Charles Ryland / Ben Willey / Susanna Gale

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQRPMATMMAMBRP
Date   Source Headline
1st Jul 20247:00 amRNSInterim Results
27th Jun 20242:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.